Baidu
map

新HPV疫苗能预防80%宫颈癌

2015-05-15 佚名 生物谷

美国的一项新研究表明,在儿童十二岁之前给他们注射最新的人乳头瘤病毒(HPV)疫苗能有80%的概率预防宫颈癌。 研究表明,该疫苗(被称为9-Valent)能预防9中不同的人乳头瘤病毒株,同时也可能能预防19,000种其他癌症,包括肛门癌和阴茎癌。新的HPV疫苗相比前一代而言,其保护作用提升了11%。研究还发现,这种疫苗可以预防5.7%的咽喉癌,而咽喉癌则是常见癌症中第二个最与HPV相关的癌症。

美国的一项新研究表明,在儿童十二岁之前给他们注射最新的人乳头瘤病毒(HPV)疫苗能有80%的概率预防宫颈癌。

研究表明,该疫苗(被称为9-Valent)能预防9中不同的人乳头瘤病毒株,同时也可能能预防19,000种其他癌症,包括肛门癌和阴茎癌。新的HPV疫苗相比前一代而言,其保护作用提升了11%。研究还发现,这种疫苗可以预防5.7%的咽喉癌,而咽喉癌则是常见癌症中第二个最与HPV相关的癌症。

美国疾病控制中心和美国Cedars-Sinai Samuel Oschin癌症防治中心检测了从1993年到2005年2670位癌症患者的HPV的DNA样本。他们试图找出有多少癌症病例是由上文提到的9种HPV引起的。

癌症防治中心的该项研究的资深领导者Marc T. Goodman在一次新闻发布会上说:“这是全球第一个关于这方面的研究,该研究不仅减少了全球癌症负担,也在一定程度上指导了儿童接种疫苗。我们还发现了70%的病人的口咽癌组织样本中含有HPV,这比以往研究中发现的都要多。可能是因为性行为的变化,如口交的增多。”而研究结果则已发表在《美国国家癌症研究所杂志》上了。

如果你已经接种了其他HPV疫苗,也无须担心。早些时候的研究已经表明,这些疫苗在预防各种癌症上都有着不小的成效,只是新的9-Valent疫苗能多提供11%的保护。不过,对抗癌症的保护自然是多多益善的。

原始出处:

Mona Saraiya, Elizabeth R. Unger, Trevor D. Thompson, Charles F. Lynch, Brenda Y. Hernandez, Christopher W. Lyu, Martin Steinau, Meg Watson, Edward J. Wilkinson, Claudia Hopenhayn, Glenn Copeland, Wendy Cozen, Edward S. Peters, Youjie Huang, Maria Sibug Saber, Sean Altekruse, Marc T. Goodman*.US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines.JNCI, May 2015.doi: 10.1093/jnci/djv086

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=24796, encodeId=0b0d24e965a, content=国内赶紧大批量上市哇!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 09:09:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23992, encodeId=6d1f2399263, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Mon May 18 02:38:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23892, encodeId=36f12389268, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:57:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407953, encodeId=0c0e140e953b2, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sun May 17 00:04:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23636, encodeId=60a2236367b, content=学习啦,值得推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 11:39:00 CST 2015, time=2015-05-16, status=1, ipAttribution=)]
    2015-05-25 jasonuclear

    国内赶紧大批量上市哇!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=24796, encodeId=0b0d24e965a, content=国内赶紧大批量上市哇!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 09:09:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23992, encodeId=6d1f2399263, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Mon May 18 02:38:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23892, encodeId=36f12389268, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:57:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407953, encodeId=0c0e140e953b2, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sun May 17 00:04:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23636, encodeId=60a2236367b, content=学习啦,值得推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 11:39:00 CST 2015, time=2015-05-16, status=1, ipAttribution=)]
    2015-05-18 zhouanxiu

    实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=24796, encodeId=0b0d24e965a, content=国内赶紧大批量上市哇!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 09:09:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23992, encodeId=6d1f2399263, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Mon May 18 02:38:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23892, encodeId=36f12389268, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:57:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407953, encodeId=0c0e140e953b2, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sun May 17 00:04:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23636, encodeId=60a2236367b, content=学习啦,值得推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 11:39:00 CST 2015, time=2015-05-16, status=1, ipAttribution=)]
    2015-05-17 huaxipanxing

    看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=24796, encodeId=0b0d24e965a, content=国内赶紧大批量上市哇!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 09:09:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23992, encodeId=6d1f2399263, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Mon May 18 02:38:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23892, encodeId=36f12389268, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:57:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407953, encodeId=0c0e140e953b2, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sun May 17 00:04:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23636, encodeId=60a2236367b, content=学习啦,值得推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 11:39:00 CST 2015, time=2015-05-16, status=1, ipAttribution=)]
    2015-05-17 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=24796, encodeId=0b0d24e965a, content=国内赶紧大批量上市哇!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 09:09:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23992, encodeId=6d1f2399263, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Mon May 18 02:38:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23892, encodeId=36f12389268, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:57:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407953, encodeId=0c0e140e953b2, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sun May 17 00:04:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23636, encodeId=60a2236367b, content=学习啦,值得推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 11:39:00 CST 2015, time=2015-05-16, status=1, ipAttribution=)]
    2015-05-16 Dr.LV

    学习啦,值得推广

    0

相关资讯

CMAJ:年轻女性接种HPV疫苗和高风险的性行为之间或并无关联

近日,一项发表于国际杂志Canadian Medical Association Journal上的研究论文中,来自加拿大皇后大学的科学家们通过研究发现,注射人乳头瘤病毒(HPV)疫苗似乎不会影响青年女性的性行为。HPV可以保护女性机体抵御四种类型的人乳头瘤病毒,人乳头瘤病毒是引发宫颈癌和肛门生殖器疣的原因。 研究者Smith说道,我们研究发现注射HPV疫苗似乎给予青年女性一种虚假的安全感,认为

J Clin Pathol:HPV疫苗对预防宫颈癌效果显著

目前发现至少13种高危(HR)型人类乳头瘤病毒(HPV)与宫颈癌的发生有关。而且,高危型HPV几乎在所有宫颈癌中出现这一概念已被广泛认可。高危型HPV同时也在85%--95%的侵袭前高级别宫颈病变(定义为宫颈上皮内瘤变(CIN)2或3级)中出现。两种经过批准使用的预防性HPV疫苗包括了病毒样粒子,可以诱导机体针对HPV16和HPV18产生强烈的免疫反应,并且发挥出几乎100%的效用。HPV16和H

WHO发布《子宫颈癌综合防治基本实践指南(第二版)》

近日,世界卫生组织(WHO)发布了《子宫颈癌综合防治基本实践指南(第二版)》,该指南旨在帮助世界各国更好地预防和控制子宫颈癌。根据WHO,子宫颈癌是全球最致命但最容易预防的女性癌症类型。在全球范围内,每年有超过27万人死于子宫颈癌,其中高达85%的死亡病例发生在发展中国家。 《子宫颈癌综合防治基本实践指南(第二版)》于2014年12月3日在澳大利亚墨尔本举行的《世界癌症领袖峰会》上发布。该指

J Natl Cancer Inst:HPV疫苗能减少人乳头状瘤病毒相关癌症

背景:本研究试图确定美国人乳头瘤病毒(HPV)相关癌症前-疫苗的特定类型,评估当前和新批准的9-价HPV疫苗对人乳头状瘤病毒类型的潜在作用。方法:疾病控制和预防中心与七个美国癌症登记处共同合作获得的从1993年到2005年间诊断的癌症的组织档案。HPV检测在2670例患者上进行,所有受试者以年龄和性别分层。人口统计的和临床数据通过解剖部位和HPV状态进行评估。当前美国癌症登记处的数据和人乳头状瘤病

HVI:HPV疫苗接种么?父母怎么看

人类乳头瘤病毒(HPV)是一种以性传播为致病主要原因的疾病,70%以上性活跃的人在其一生中至少感染一次HPV病毒。持续感染某些亚型的HPV可能导致宫颈癌这一女性第二常见癌症、头颈和其他类型的癌症以及男性和女性肛门-生殖器疣。目前,HPV疫苗已被证明是安全的,并几乎100%在广泛的临床试验中有效且应用于相应的领域。然而,针对年轻女孩进行常规疫苗接种的这一想法,却引起了公众的广泛热议。蒙特利尔麦吉尔大

HPV疫苗可提供长效保护

近期研究表明,在德国每年约有11.2/100 000的妇女会得宫颈癌。持续感染高危人乳头瘤病毒(HPV)是宫颈发育不良和宫颈瘤形成的一个必要的先决条件。人类乳头瘤病毒疫苗接种是一个备受争议和讨论的话题,因为在2007年它被德国常务委员会纳入到疫苗接种建议(STIKO)中。研究人员进行了系统回顾显示针对16型和18型HPV疫苗的保护期超过了5年以上。 德国市场授权的疫苗是针对16型和18型的H

Baidu
map
Baidu
map
Baidu
map